Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Camden National ( (CAC) ) has shared an announcement.
Camden National Corporation recently completed the acquisition of Northway Financial, which was finalized on January 2, 2025, with systems conversion in March 2025. The acquisition is expected to enhance Camden National’s presence in Northern New England, with significant cost savings and increased earnings per share anticipated. The company’s strategic objectives include expanding commercial banking, bolstering wealth management, and leveraging digital innovations to drive growth and operational excellence.
The most recent analyst rating on (CAC) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.
Spark’s Take on CAC Stock
According to Spark, TipRanks’ AI Analyst, CAC is a Outperform.
Camden National’s overall stock score reflects a solid financial foundation with strong earnings growth and attractive valuation. The positive sentiment from the earnings call further supports the score, despite some challenges in cash flow and potential future expenses. Technical indicators suggest a neutral market position, contributing to a balanced outlook.
To see Spark’s full report on CAC stock, click here.
More about Camden National
Camden National Corporation is the largest publicly traded bank headquartered in Northern New England, established in 1875. It operates as the parent company of Camden National Bank, with $7.0 billion in assets, $5.0 billion in loans, and $5.4 billion in deposits. The company has a strong presence with 72 branches and over 700 employees, focusing on providing diversified financial services.
Average Trading Volume: 69,361
Technical Sentiment Signal: Buy
Current Market Cap: $647.2M
See more insights into CAC stock on TipRanks’ Stock Analysis page.

